Circulating CD3⁺CD4⁺CD161⁺ Cells Are Associated with Early Complications after Autologous Stem Cell Transplantation in Multiple Myeloma

Figure 1

Proportions of pretransplant CD3⁺CD4⁺CD161⁺ cells according to (a) the occurrence of mucositis (≥grade 3), (b) infection before engraftment, and (c) CMV reactivation.

(a)

(b)

(c)